Population-Level Impacts of Non-Medical Cannabis Legalization and Commercialization on Psychosis-Related Outcomes
2024
- 72Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage72
- Abstract Views69
- Downloads3
Article Description
The legalization of non-medical cannabis has raised concerns regarding potential impacts on psychotic disorders. The objective of this thesis was to investigate the population-level effects of non-medical cannabis legalization on psychotic disorders. The findings from our scoping review suggest that as the non-medical cannabis retail market expanded, increases in health service use for psychotic disorders were observed; however, no changes were observed during a time of market restrictions. We then conducted an ecological study, which found quarterly regional cannabis sales per capita was correlated with quarterly prevalence of emergency department visits and hospitalizations for psychotic disorders. These findings suggest that the expansion of the non-medical cannabis market may lead to increases in health service use for psychotic disorders. Further research is needed to understand the mental health implications of cannabis legalization and whether policy changes need to be made to cannabis product availability and resourcing of mental health services.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know